{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:41:39Z","timestamp":1772232099469,"version":"3.50.1"},"reference-count":44,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:p>OBJECTIVE. High doses of dexamethasone reduce the risk of chronic lung disease among premature infants but may increase the risk of developmental impairments. The objective of this study was to compare developmental outcomes beyond infancy for children who, as neonates, participated in a randomized trial of dexamethasone.<\/jats:p>\n                  <jats:p>PATIENTS AND METHODS. One hundred eighteen children with birth weights &amp;lt;1500 g were randomly assigned at 15 to 25 days of life to a 42-day tapering course of dexamethasone or placebo. All 95 survivors were assessed by using standardized measures of developmental outcome at least once at or beyond 1 year of age, and 84 were examined at 4 to 11 years. For this follow-up study, the outcome of primary interest was death or major neurodevelopmental impairment, which was defined as cerebral palsy, cognitive impairment, or blindness.<\/jats:p>\n                  <jats:p>RESULTS. On the basis of each child's most recent follow-up, the rates of major neurodevelopmental impairments were 40% for the dexamethasone group and 20% for the placebo group. The higher impairment rate for the dexamethasone group was mainly attributed to a higher prevalence of cerebral palsy. Rates of the composite outcome of death or major neurodevelopmental impairment were 47% and 41%, respectively.<\/jats:p>\n                  <jats:p>CONCLUSION. A 42-day tapering course of dexamethasone, which was shown previously to decrease the risk of chronic lung disease in very low birth weight infants, does not increase the risk of the composite outcome of death or major neurodevelopmental impairment.<\/jats:p>","DOI":"10.1542\/peds.2007-0486","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T12:34:17Z","timestamp":1188563657000},"page":"594-602","source":"Crossref","is-referenced-by-count":54,"title":["Follow-up of a Randomized, Placebo-Controlled Trial of Dexamethasone to Decrease the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Neurodevelopmental Outcomes at 4 to 11 Years of Age"],"prefix":"10.1542","volume":"120","author":[{"given":"T. Michael","family":"O'Shea","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Washburn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Nixon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine"},{"name":"Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"2021120902253806800_R1","doi-asserted-by":"crossref","unstructured":"Baden M, Bauer CR, Cole E, Klein G, Taeusch HW, Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics.\u20081972;50:526\u2013534","DOI":"10.1542\/peds.50.4.526"},{"key":"2021120902253806800_R2","doi-asserted-by":"crossref","unstructured":"Gladstone IM, Ehrenkranz RA, Jacobs HC. Pulmonary function tests and fluid balance in neonates with chronic lung disease during dexamethasone treatment. Pediatrics.\u20081989;84:1072\u20131076","DOI":"10.1542\/peds.84.6.1072"},{"key":"2021120902253806800_R3","doi-asserted-by":"crossref","unstructured":"Yoder MC Jr, Chua R, Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis.\u20081991;143:1044\u20131048","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1044"},{"key":"2021120902253806800_R4","doi-asserted-by":"crossref","unstructured":"Brundage KL, Mohsini KG, Froese AB, Walker CR, Fisher JT. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression. Pediatr Pulmonol.\u20081992;12:162\u2013169","DOI":"10.1002\/ppul.1950120307"},{"key":"2021120902253806800_R5","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (&lt;96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001146","DOI":"10.1002\/14651858.CD001146"},{"key":"2021120902253806800_R6","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7\u201314 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001144","DOI":"10.1002\/14651858.CD001144"},{"key":"2021120902253806800_R7","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (&gt;3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001145","DOI":"10.1002\/14651858.CD001145"},{"key":"2021120902253806800_R8","doi-asserted-by":"crossref","unstructured":"Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics.\u20082006;117:75\u201383","DOI":"10.1542\/peds.2004-2843"},{"key":"2021120902253806800_R9","doi-asserted-by":"crossref","unstructured":"Papile LA, Tyson JE, Stoll BJ, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med.\u20081998;338:1112\u20131118","DOI":"10.1056\/NEJM199804163381604"},{"key":"2021120902253806800_R10","doi-asserted-by":"crossref","unstructured":"Anderson ME, Bednarek FJ, Dreyer G, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics.\u20082001;108:741\u2013748","DOI":"10.1542\/peds.108.3.741"},{"key":"2021120902253806800_R11","doi-asserted-by":"crossref","unstructured":"Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr.\u20082001;1:1","DOI":"10.1186\/1471-2431-1-1"},{"key":"2021120902253806800_R12","doi-asserted-by":"crossref","unstructured":"Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med.\u20082004;350:1304\u20131313","DOI":"10.1056\/NEJMoa032089"},{"key":"2021120902253806800_R13","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics.\u20082002;109:330\u2013338","DOI":"10.1542\/peds.109.2.330"},{"key":"2021120902253806800_R14","doi-asserted-by":"crossref","unstructured":"Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics.\u20082005;115:655\u2013661","DOI":"10.1542\/peds.2004-1238"},{"key":"2021120902253806800_R15","doi-asserted-by":"crossref","unstructured":"Kothadia JM, O'Shea TM, Roberts D, Auringer ST, Weaver RG III, Dillard RG. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants [published correction appears in Pediatrics. 2004;114:1746]. Pediatrics.\u20081999;104:22\u201327","DOI":"10.1542\/peds.104.1.22"},{"key":"2021120902253806800_R16","doi-asserted-by":"crossref","unstructured":"O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics.\u20081999;104:15\u201321","DOI":"10.1542\/peds.104.1.15"},{"key":"2021120902253806800_R17","doi-asserted-by":"crossref","unstructured":"Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal-period. Pediatrics.\u20081988;82:527\u2013532","DOI":"10.1542\/peds.82.4.527"},{"key":"2021120902253806800_R18","doi-asserted-by":"crossref","unstructured":"Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol.\u20081996;87:163\u2013168","DOI":"10.1016\/0029-7844(95)00386-X"},{"key":"2021120902253806800_R19","doi-asserted-by":"crossref","unstructured":"Stewart AL, Reynolds EO, Hope PL, et al. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Dev Med Child Neurol.\u20081987;29:3\u201311","DOI":"10.1111\/j.1469-8749.1987.tb02101.x"},{"key":"2021120902253806800_R20","doi-asserted-by":"crossref","unstructured":"Paneth N. Classifying brain damage in preterm infants. J Pediatr.\u20081999;134:527\u2013529","DOI":"10.1016\/S0022-3476(99)70231-3"},{"key":"2021120902253806800_R21","unstructured":"Elliott CD. Differential Abilities Scales: Administration and Scoring Manual. San Antonio, TX: Psychological Corporation; 1990"},{"key":"2021120902253806800_R22","unstructured":"Kaufman AS, Kaufman NL. Manual for the Kaufman Test of Educational Achievement: Comprehensive Form. Circle Pines, MN: American Guidance Service; 1998"},{"key":"2021120902253806800_R23","unstructured":"Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavioral Scales. Circle Pines, MN: American Guidance Service; 1984"},{"key":"2021120902253806800_R24","unstructured":"Wechsler D. Wechsler Individual Achievement Test. San Antonio, TX: Psychological Corporation; 1992"},{"key":"2021120902253806800_R25","unstructured":"Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. New York, NY: Psychological Corporation; 1991"},{"key":"2021120902253806800_R26","unstructured":"Grossman H, ed. Classification in Mental Retardation. Washington, DC: American Association on Mental Deficiency; 1983"},{"key":"2021120902253806800_R27","doi-asserted-by":"crossref","unstructured":"Nixon PA, Washburn LK, Schechter MS, O'Shea TM. Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. J Pediatr.\u20082007;150:345\u2013350","DOI":"10.1016\/j.jpeds.2006.12.013"},{"key":"2021120902253806800_R28","doi-asserted-by":"crossref","unstructured":"Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med.\u20081989;320:1505\u20131510","DOI":"10.1056\/NEJM198906083202301"},{"key":"2021120902253806800_R29","doi-asserted-by":"crossref","unstructured":"Gross SJ, Anbar RD, Mettelman BB. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics.\u20082005;115:681\u2013687","DOI":"10.1542\/peds.2004-0956"},{"key":"2021120902253806800_R30","doi-asserted-by":"crossref","unstructured":"Edwards HE, Burnham WM. The impact of corticosteroids on the developing animal. Pediatr Res.\u20082001;50:433\u2013440","DOI":"10.1203\/00006450-200110000-00003"},{"key":"2021120902253806800_R31","doi-asserted-by":"crossref","unstructured":"Murphy BP, Inder TE, Huppi PS, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics.\u20082001;107:217\u2013221","DOI":"10.1542\/peds.107.2.217"},{"key":"2021120902253806800_R32","doi-asserted-by":"crossref","unstructured":"Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed.\u20082000;83:F177\u2013F181","DOI":"10.1136\/fn.83.3.F177"},{"key":"2021120902253806800_R33","doi-asserted-by":"crossref","unstructured":"Yeh TF, Lin YJ, Hsieh WS, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics.\u20081997;100(4). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/4\/e3","DOI":"10.1542\/peds.100.4.e3"},{"key":"2021120902253806800_R34","doi-asserted-by":"crossref","unstructured":"Romagnoli C, Zecca E, Luciano R, Torriolil G, Tortorolo G. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. Pediatrics.\u20082002;109(6). Available at: www.pediatrics.org\/cgi\/content\/full\/109\/6\/e85","DOI":"10.1542\/peds.109.6.e85"},{"key":"2021120902253806800_R35","unstructured":"Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics.\u20081991;88:421\u2013427"},{"key":"2021120902253806800_R36","doi-asserted-by":"crossref","unstructured":"O'Shea TM. Definition and classification of cerebral palsy: an epidemiologist perspective. Dev Med Child Neurol.\u20082007;49:29\u201330","DOI":"10.1111\/j.1469-8749.2007.tb12622.x"},{"key":"2021120902253806800_R37","doi-asserted-by":"crossref","unstructured":"Hille ETM, Elbertse L, Gravenhorst JB, Brand R, Verloove-Vanhorick SP; Dutch POPS-19 Collaborative Study Group. Nonresponse bias in a follow-up study of 19-year-old adolescents born as preterm infants. Pediatrics.\u20082005;116(5). Available at: www.pediatrics.org\/cgi\/content\/full\/116\/5\/e662","DOI":"10.1542\/peds.2005-0682"},{"key":"2021120902253806800_R38","doi-asserted-by":"crossref","unstructured":"Tin W, Fritz S, Wariyar U, Hey E. Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty. Arch Dis Child Fetal Neonatal Ed.\u20081998;79:F83\u2013F87","DOI":"10.1136\/fn.79.2.F83"},{"key":"2021120902253806800_R39","doi-asserted-by":"crossref","unstructured":"Aylward GP, Hatcher RP, Stripp B, Gustafson NF, Leavitt LA. Who goes and who stays: subject loss in a multicenter, longitudinal follow-up-study. J Dev Behav Pediatr.\u20081985;6:3\u20138","DOI":"10.1097\/00004703-198502000-00003"},{"key":"2021120902253806800_R40","doi-asserted-by":"crossref","unstructured":"Hack M, Taylor HG, Drotar D, et al. Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age. Pediatrics.\u20082005;116:333\u2013341","DOI":"10.1542\/peds.2005-0173"},{"key":"2021120902253806800_R41","doi-asserted-by":"crossref","unstructured":"Roth SC, Baudin J, Pezzani-Goldsmith M, Townsend J, Reynolds EO, Stewart AL. Relation between neurodevelopmental status of very preterm infants at one and eight years. Dev Med Child Neurol.\u20081994;36:1049\u20131062","DOI":"10.1111\/j.1469-8749.1994.tb11808.x"},{"key":"2021120902253806800_R42","doi-asserted-by":"crossref","unstructured":"Bose CL, Laughon MM. Corticosteroids and chronic lung disease: time for another randomized, controlled trial. Pediatrics.\u20082005;115:794","DOI":"10.1542\/peds.2004-2203"},{"key":"2021120902253806800_R43","doi-asserted-by":"crossref","unstructured":"Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics.\u20082005;116:1353\u20131360","DOI":"10.1542\/peds.2005-0249"},{"key":"2021120902253806800_R44","doi-asserted-by":"crossref","unstructured":"Saigal S, Stoskopf B, Pinelli J, et al. Self-perceived health-related quality of life of former extremely low birth weight infants at young adulthood. Pediatrics.\u20082006;118:1140\u20131148","DOI":"10.1542\/peds.2006-0119"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/3\/594\/1120632\/zpe00907000594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/3\/594\/1120632\/zpe00907000594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T19:51:00Z","timestamp":1684007460000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/3\/594\/71162\/Follow-up-of-a-Randomized-Placebo-Controlled-Trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,9,1]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0486","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1091074.544459","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}